4 completed, 3 terminated. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Terminated 3 |
Follow satavaptan: new trials by email Literature Review of satavaptan trials Research Report on satavaptan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Satavaptan, placebo - Hyponatremia, Inappropriate ADH Syndrome | Phase 3 | Terminated | Sanofi | 2 | 2008-07-01 | 2016-05-26 |
| Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver Satavaptan, placebo - Ascites, Liver Cirrhosis | Phase 3 | Terminated | Sanofi | 241 | 2006-08-01 | 2016-05-18 |
| Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) Satavaptan, placebo - Ascites, Liver Cirrhosis | Phase 3 | Completed | Sanofi | 463 | 2006-07-01 | 2016-05-26 |
| Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver Satavaptan, placebo - Ascites, Liver Cirrhosis | Phase 3 | Terminated | Sanofi | 501 | 2006-07-01 | 2016-05-24 |
| Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion SR121463B - Inappropriate ADH Syndrome, Hyponatremia | Phase 3 | Completed | Sanofi | 57 | 2005-07-01 | 2009-01-21 |
| DILIPO (DILutIonal HyPOnatremia) SR121463B - Congestive Heart Failure | Phase 3 | Completed | Sanofi | 150 | 2005-05-01 | 2008-09-15 |
| Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion SR121463B - Inappropriate ADH Syndrome, Hyponatremia | Phase 3 | Completed | Sanofi | 77 | 2004-05-01 | 2008-12-10 |
Hyponatremia (4) · Ascites (3) · Inappropriate ADH Syndrome (3) · Liver Cirrhosis (3) · Heart Failure (1)
Sanofi (7)
United States (7) · Belgium (6) · Canada (6) · Australia (5) · Hungary (5) · Argentina (4) · Brazil (4) · France (4) · Germany (4) · Portugal (4) · Romania (4) · Spain (4) · Chile (3) · Croatia (3) · Israel (3)